ReP USP - Resultado da busca

Artigo de periodico
Atypical ocular Chelonoid herpesvirus manifestations in a captive Loggerhead turtle (Caretta caretta) (2021)
Oriá, Arianne P ; Silva, Danielle N; Raposo, Ana Cláudia ; Estrela-Lima, Alessandra ; Pires, Thaís T; Gattamorta, Marco Aurélio ; Zamana, Roberta Ramblas; Matushima, Eliana Reiko ; Ofri, Ron
Source: Veterinary Ophthalmology. Unidade: FMVZ
Subjects: ALPHAHERPESVIRINAE, CONJUNTIVITE ANIMAL, TARTARUGA MARINHA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORIÁ, Arianne P et al. Atypical ocular Chelonoid herpesvirus manifestations in a captive Loggerhead turtle (Caretta caretta). Veterinary Ophthalmology, v. 24, n. 1, p. 97-102, 2021Tradução . . Disponível em: https://doi.org/10.1111/vop.12837. Acesso em: 17 nov. 2024.
APA
Oriá, A. P., Silva, D. N., Raposo, A. C., Estrela-Lima, A., Pires, T. T., Gattamorta, M. A., et al. (2021). Atypical ocular Chelonoid herpesvirus manifestations in a captive Loggerhead turtle (Caretta caretta). Veterinary Ophthalmology, 24( 1), 97-102. doi:10.1111/vop.12837
NLM
Oriá AP, Silva DN, Raposo AC, Estrela-Lima A, Pires TT, Gattamorta MA, Zamana RR, Matushima ER, Ofri R. Atypical ocular Chelonoid herpesvirus manifestations in a captive Loggerhead turtle (Caretta caretta) [Internet]. Veterinary Ophthalmology. 2021 ; 24( 1): 97-102.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/vop.12837
Vancouver
Oriá AP, Silva DN, Raposo AC, Estrela-Lima A, Pires TT, Gattamorta MA, Zamana RR, Matushima ER, Ofri R. Atypical ocular Chelonoid herpesvirus manifestations in a captive Loggerhead turtle (Caretta caretta) [Internet]. Veterinary Ophthalmology. 2021 ; 24( 1): 97-102.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/vop.12837
Artigo de periodico
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL Study (2018)
Fox, Philip R; Keene, Bruce W; Lamb, Kenneth; Schober, Karsten A; Chetboul, Valerie; Fuentes, Virginia Luis; Wess, Gerhard; Payne, Jessie Rose; Hogan, Daniel F; Motsinger-Reif, Alison; Häggström, Jens; Trehiou-Sechi, Emilie; Fine-Ferreira, Deborah M; Nakamura, Reid K; Lee, Pamela M; Singh, Manreet K; Ware, Wendy A; Abbott, Jonathan A; Culshaw, Geoffrey; Riesen, Sabine; Borgarelli, Michele; Lesser, Michael B; Israël, Nicole Van; Côté, Etienne; Rush, John E; Bulmer, Barret; Santilli, Roberto A; Vollmar, Andrea C; Bossbaly, Maribeth J; Quick, Nadine; Bussadori, Claudio; Bright, Janice M; Estrada, Amara H; Ohad, Dan G; Palacio, Maria Josefa Fernández-Del; Brayley, Jenifer Lunney; Schwartz, Denise Saretta ; Bové, Christina M; Gordon, Sonya G; Jung, Seung Woo; Brambilla, Paola; Moïse, N. Sydney; Stauthammer, Christopher D; Stepien, Rebecca L; Quintavalla, Cecilia; Amberger, Christophe; Manczur, Ferenc; Hung, Yong-Wei; Lobetti, Remo; Swarte, Marie De; Tamborini, Alice; Mooney, Carmel T; Oyama, Mark A; Komolov, Andrey; Fujii, Yoko; Pariaut, Romain; Uechi, Masami; Ohara, Victoria Yukie Tachika
Source: Journal of Veterinary Internal Medicine. Unidade: FMVZ
Subjects: DOENÇAS CARDIOVASCULARES EM ANIMAL, GATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOX, Philip R et al. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL Study. Journal of Veterinary Internal Medicine, v. 32, n. 3, p. 930-943, 2018Tradução . . Disponível em: https://doi.org/10.1111/jvim.15122. Acesso em: 17 nov. 2024.
APA
Fox, P. R., Keene, B. W., Lamb, K., Schober, K. A., Chetboul, V., Fuentes, V. L., et al. (2018). International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL Study. Journal of Veterinary Internal Medicine, 32( 3), 930-943. doi:10.1111/jvim.15122
NLM
Fox PR, Keene BW, Lamb K, Schober KA, Chetboul V, Fuentes VL, Wess G, Payne JR, Hogan DF, Motsinger-Reif A, Häggström J, Trehiou-Sechi E, Fine-Ferreira DM, Nakamura RK, Lee PM, Singh MK, Ware WA, Abbott JA, Culshaw G, Riesen S, Borgarelli M, Lesser MB, Israël NV, Côté E, Rush JE, Bulmer B, Santilli RA, Vollmar AC, Bossbaly MJ, Quick N, Bussadori C, Bright JM, Estrada AH, Ohad DG, Palacio MJF-D, Brayley JL, Schwartz DS, Bové CM, Gordon SG, Jung SW, Brambilla P, Moïse NS, Stauthammer CD, Stepien RL, Quintavalla C, Amberger C, Manczur F, Hung Y-W, Lobetti R, Swarte MD, Tamborini A, Mooney CT, Oyama MA, Komolov A, Fujii Y, Pariaut R, Uechi M, Ohara VYT. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL Study [Internet]. Journal of Veterinary Internal Medicine. 2018 ; 32( 3): 930-943.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/jvim.15122
Vancouver
Fox PR, Keene BW, Lamb K, Schober KA, Chetboul V, Fuentes VL, Wess G, Payne JR, Hogan DF, Motsinger-Reif A, Häggström J, Trehiou-Sechi E, Fine-Ferreira DM, Nakamura RK, Lee PM, Singh MK, Ware WA, Abbott JA, Culshaw G, Riesen S, Borgarelli M, Lesser MB, Israël NV, Côté E, Rush JE, Bulmer B, Santilli RA, Vollmar AC, Bossbaly MJ, Quick N, Bussadori C, Bright JM, Estrada AH, Ohad DG, Palacio MJF-D, Brayley JL, Schwartz DS, Bové CM, Gordon SG, Jung SW, Brambilla P, Moïse NS, Stauthammer CD, Stepien RL, Quintavalla C, Amberger C, Manczur F, Hung Y-W, Lobetti R, Swarte MD, Tamborini A, Mooney CT, Oyama MA, Komolov A, Fujii Y, Pariaut R, Uechi M, Ohara VYT. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL Study [Internet]. Journal of Veterinary Internal Medicine. 2018 ; 32( 3): 930-943.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/jvim.15122
Artigo de periodico
Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative (2017)
Silva, Nicole R.; Gomes, Felipe V.; Fonseca, Miriam D.; Mechoulam, Raphael; Breuer, Aviva; Cunha, Thiago Mattar; Guimarães, Francisco Silveira
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, ANALGÉSICOS, NOCICEPTORES, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Nicole R. et al. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 79, p. 369-377, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2017.07.012. Acesso em: 17 nov. 2024.
APA
Silva, N. R., Gomes, F. V., Fonseca, M. D., Mechoulam, R., Breuer, A., Cunha, T. M., & Guimarães, F. S. (2017). Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 79, 369-377. doi:10.1016/j.pnpbp.2017.07.012
NLM
Silva NR, Gomes FV, Fonseca MD, Mechoulam R, Breuer A, Cunha TM, Guimarães FS. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2017 ; 79 369-377.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.07.012
Vancouver
Silva NR, Gomes FV, Fonseca MD, Mechoulam R, Breuer A, Cunha TM, Guimarães FS. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2017 ; 79 369-377.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.07.012
Artigo de periodico
Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects (2016)
Breuer, Aviva; Haj, Christeene G.; Fogaça, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Pedrazzi, João Francisco; Del Bel, Elaine Aparecida; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Zuardi, Antônio Waldo; Mechoulam, Raphael; Guimarães, Francisco Silveira
Source: PLOS ONE. Unidades: FORP, FMRP
Subjects: CANABINOIDES, FLUORAÇÃO, NEUROPSIQUIATRIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BREUER, Aviva et al. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects. PLOS ONE, v. 11, n. 8, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0162087. Acesso em: 17 nov. 2024.
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects. PLOS ONE, 11( 8). doi:10.1371/journal.pone.0162087
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects [Internet]. PLOS ONE. 2016 ; 11( 8):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1371/journal.pone.0162087
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects [Internet]. PLOS ONE. 2016 ; 11( 8):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1371/journal.pone.0162087
Artigo de periodico
Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics (2016)
Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro; Chazova, Irina; Dans, Antonio; Diaz, Rafael; Fodor, George J.; Held, Claes; Jansky, Petr; Keltai, Matyas; Keltai, Katalin; kunti, Kamlesh; Kim, Jae-Hyung; Leiter, Lawrence; Lewis, Basil; Liu, Lisheng; Lopez-Jaramillo, Patricio; Pais, Prem; Parkhomenko, Alexandr; Peters, Ron J. G; Piegas, Leopoldo S; Reid, Christopher M; Sliwa, Karen; Toff, William D; Varigos, John; Xavier, Denis; Yusoff, Khalid; Zhu, Jun; Dagenais, Gilles; Yusuf, Salim; Marin Neto, José Antonio
Source: Canadian Journal of Cardiology. Unidade: FMRP
Subjects: RECEPTORES DE ANGIOTENSINA, PRESSÃO SANGUÍNEA, DOENÇAS CARDIOVASCULARES, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva et al. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, v. 32, n. 3, p. 311-318, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.cjca.2015.07.001. Acesso em: 17 nov. 2024.
APA
Lonn, E., Bosch, J., Pogue, J., Avezum, A., Chazova, I., Dans, A., et al. (2016). Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, 32( 3), 311-318. doi:10.1016/j.cjca.2015.07.001
NLM
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Vancouver
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Artigo de periodico
Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (2016)
Breuer, Aviva; Haj, Christeene G.; Fogaça, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Pedrazzi, João Francisco; Del Bel, Elaine Aparecida; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Zuardi, Antônio Waldo; Mechoulam, Raphael; Guimarães, Francisco Silveira
Source: PLoS ONE. Unidades: FORP, FMRP
Subjects: CANABINOIDES, FLUORAÇÃO, NEUROPSIQUIATRIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BREUER, Aviva et al. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, v. 11, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0158779. Acesso em: 17 nov. 2024.
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, 11. doi:10.1371/journal.pone.0158779
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2024 nov. 17 ] Available from: https://doi.org/10.1371/journal.pone.0158779
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2024 nov. 17 ] Available from: https://doi.org/10.1371/journal.pone.0158779

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Indexado em

Non normalized affiliation

Countries of institutions of collaboration